<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2024</YEAR>
<VOL>22</VOL>
<NO>3</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>245</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Comparing the advantages, disadvantages and diagnostic power of different non-invasive pre-implantation genetic testing: A literature review</TitleF>
		<TitleE>مقایسه مزایا و معایب و قدرت انواع روش‌های تشخیص ژنتیکی غیرتهاجمی پیش از کاشت: مروری بر متون</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>به منظور بهبود میزان موفقیت انتقال جنین و افزایش شانس تولد زنده در روش&#173;های کمک&#173;باروری، تقاضای فزاینده&#173;ای برای استفاده از تست&#173;های تشخیص ژنتیکی قبل از لانه&#173;گزینی (PGT) وجود دارد. با این حال، رویکردهای تهاجمی مورد استفاده در PGT منجر به شکست لقاح خارج رحمی و سقط جنین و در نتیجه افزایش سطح اضطراب برای والدین شده است. برای رفع این مشکل، روش&#8204;های غیرتهاجمی PGT مانند تشخیص DNA در مایع بلاستوکول بلاستوسیست&#8204;ها و محیط&#8204;های کشت مصرف&#8204;شده (SCM) معرفی شده&#8204;اند. این روش&#173;ها ثابت کرده&#173;اند که در تشخیص آنوپلوئیدی در کروموزوم&#173;های جنین انسان کم&#173;تهاجمی و مؤثر هستند. هدف این مقاله، بررسی رویکردهای مختلف تشخیص قبل از کاشت، از جمله روش&#8204;های تهاجمی و غیرتهاجمی، با تمرکز ویژه بر niPGT است. استراتژی جستجو شامل جمع&#173;آوری داده&#173;ها از پایگاه&#173;های علمی مانند PubMed، Google Scholar و Science Direct با استفاده از کلمات کلیدی مرتبط بود. جستجو تا ژانویه 2023 انجام شد. در مجموع، 22 مطالعه با موفقیت تشخیص و تکثیر DNA بدون سلول در SCM جنینی را گزارش کردند. توجه به این نکته مهم است که niPGT دارای محدودیت&#173;هایی است که ناشی از تفاوت در شاخص&#173;هایی مانند نرخ تکثیر DNA بدون سلول، تطابق، سطح آلودگی DNA مادری، حساسیت و ویژگی بین نمونه&#173;های SCM و سلول&#173;های بیوپسی شده است. بنابراین، تحقیقات گسترده&#8204;تر و دقیق&#8204;تری برای درک کامل پتانسیل niPGT برای کاربردهای بالینی مورد نیاز است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>To improve embryo transfer success and increase the chances of live birth in assisted reproductive methods, there is a growing demand for the use of pre-implantation genetic testing (PGT). However, the invasive approaches used in PGT have led to in vitro fertilization failure and abortions, increasing anxiety levels for parents. To address this, non-invasive PGT methods have been introduced, such as the detection of DNA in blastocoel fluid of blastocysts and spent culture media (SCM). These methods have proven to be minimally invasive and effective in detecting aneuploidy in the chromosomes of human embryos. This review aims to explore the different approaches to pre-implantation diagnosis, including invasive and non-invasive methods, with a particular focus on non-invasive PGT (niPGT). The search strategy involved gathering data from scientific databases such as PubMed, Google Scholar, and Science Direct using relevant keywords. The search was conducted until January 2023. In total, 22 studies have successfully reported the detection and amplification of cell-free DNA in the embryonic SCM. It is important to note that niPGT has some limitations, which include differences in indicators such as cell-free DNA amplification rate, concordance, level of maternal DNA contamination, sensitivity, and specificity between SCM samples and biopsied cells. Therefore, more extensive and detailed research is needed to fully understand niPGT&#39;s potential for clinical applications.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>177</FPAGE>
			<TPAGE>190</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/5/25
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/3
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Noorodin</Name>
				<MidName></MidName>
				<Family>Karami</Family>
				<NameE>Noorodin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karami</FamilyE>
				<Organizations>
				<Organization>Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Noorodin.karami@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farzaneh</Name>
				<MidName></MidName>
				<Family>Iravani</Family>
				<NameE>Farzaneh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Iravani</FamilyE>
				<Organizations>
				<Organization>Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Farzaneh.baroon@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sareh</Name>
				<MidName></MidName>
				<Family>Bakhshandeh Bavarsad</Family>
				<NameE>Sareh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bakhshandeh Bavarsad</FamilyE>
				<Organizations>
				<Organization>Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>S.bakhshandeh27@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Samira</Name>
				<MidName></MidName>
				<Family>Asadollahi</Family>
				<NameE>Samira</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asadollahi</FamilyE>
				<Organizations>
				<Organization>Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Research Center for Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Sasadullahi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyed Mehdi</Name>
				<MidName></MidName>
				<Family>Hoseini</Family>
				<NameE>Seyed Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hoseini</FamilyE>
				<Organizations>
				<Organization>Biotechnology Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Science, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>sm_hoseini@outlook.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fateme</Name>
				<MidName></MidName>
				<Family>Montazeri</Family>
				<NameE>Fateme</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Montazeri</FamilyE>
				<Organizations>
				<Organization>Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>f_montazeri@outlook.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyed Mehdi</Name>
				<MidName></MidName>
				<Family>Kalantar</Family>
				<NameE>Seyed Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kalantar</FamilyE>
				<Organizations>
				<Organization>Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>smkyzd@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Spent culture media</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Non-invasive pre-implantation genetic testing</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Biopsy methods</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cell-free embryonic DNA.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>محیط‌ کشت مصرف‌شده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تست‌های ژنتیکی قبل از کاشت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روش‌های بیوپسی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>DNA بدون سلول جنین.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Cheng W-L, Hsiao Ch-H, Tseng H-W, Lee T-P. Noninvasive prenatal diagnosis. Taiwan J Obstet Gynecol 2015; 54: 343-349.##Nguyen MTM, Knoppers BM. Prenatal and preimplantation diagnosis: International policy perspectives. In: Milunsky A, Milunsky JM. Genetic disorders and the fetus: Diagnosis, prevention, and treatment. 8th Ed. US: Wiley-Blackwell Publisher; 2015.##Fleddermann L, Hashmi SS, Stevens B, Murphy L, Rodriguez-Buritica D, Friel LA, et al. Current genetic counseling practice in the United States following positive non-invasive prenatal testing for sex chromosome abnormalities. J Genet Couns 2019; 28: 802-811.##Dahdouh EM, Balayla J, García-Velasco JA. Comprehensive chromosome screening improves embryo selection: A meta-analysis. Fertil Steril 2015; 104: 1503-1512.##El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet P-E. Recurrent pregnancy loss: Current perspectives. Int J Womens Health 2017; 9: 331-345.##Schmutzler AG. Theory and practice of preimplantation genetic screening (PGS). Eur J Med Genet 2019; 62: 103670.##Sullivan-Pyke Ch, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin 2018; 45: 113-125.##Chen H-F, Chen S-U, Ma G-C, Hsieh S-T, Tsai H-D, Yang Y-S, et al. Preimplantation genetic diagnosis and screening: Current status and future challenges. J Formos Med Assoc 2018; 117: 94-100.##Munné S. Status of preimplantation genetic testing and embryo selection. Reprod Biomed Online 2018; 37: 393-396.##Greco E, Litwicka K, Minasi MG, Cursio E, Greco PF, Barillari P. Preimplantation genetic testing: Where we are today. Int J Mol Sci 2020; 21: 4381.##Fesahat F, Montazeri F, Hoseini SM. Preimplantation genetic testing in assisted reproduction technology. J Gynecol Obstet Hum Reprod 2020; 49: 101723.##Chada AR, Crawford S, Hipp HS, Kawwass JF. Trends and outcomes for preimplantation genetic testing for monogenic disorders in the United States, 2014-2018. Fertil Steril 2022; 118: 1190-1193.##https://doi.org/10.1016/j.fertnstert.2022.08.100##Parikh FR, Athalye AS, Kulkarni DK, Sanap RR, Dhumal SB, Warang DJ, et al. Evolution and utility of preimplantation genetic testing for monogenic disorders in assisted reproduction: A narrative review. J Hum Reprod Sci 2021; 14: 329-339.##De Rycke M, Berckmoes V. Preimplantation genetic testing for monogenic disorders. Genes (Basel) 2020; 11: 871.##Mateu-Brull E, Rodrigo L, Peinado V, Mercader A, Campos-Galindo I, Bronet F, et al. Interchromosomal effect in carriers of translocations and inversions assessed by preimplantation genetic testing for structural rearrangements (PGT-SR). J Assist Reprod Genet 2019; 36: 2547-2555.##Wu TF, Chen MJ, Lee MS, Huang CC, Ho ST, Cheng EH, et al. Comparison of clinical outcome between day 5 and day 6 single blastocyst transfers in cycles undergoing preimplantation genetic testing for aneuploidy. Taiwan J Obstet Gynecol 2023; 62: 429-433.##Dong Z, Wang H, Chen H, Jiang H, Yuan J, Yang Z, et al. Identification of balanced chromosomal rearrangements previously unknown among participants in the 1000 genomes project: Implications for interpretation of structural variation in genomes and the future of clinical cytogenetics. Genet Med 2018; 20: 697-707.##Kakourou G, Mamas T, Vrettou C, Traeger-Synodinos J. An update on non-invasive approaches for genetic testing of the preimplantation embryo. Curr Genomics 2022; 23: 337-352.##Li X, Hao Y, Chen D, Ji D, Zhu W, Zhu X, et al. Non-invasive preimplantation genetic testing for putative mosaic blastocysts: A pilot study. Hum Reprod 2021; 36: 2020-2034.##Treff NR, Zimmerman R, Bechor E, Hsu J, Rana B, Jensen J, et al. Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platform. Eur J Med Genet 2019; 62: 103647.##Farra C, Choucair F, Awwad J. Non-invasive pre-implantation genetic testing of human embryos: An emerging concept. Hum Reprod 2018; 33: 2162-2167.##Xu J, Fang R, Chen L, Chen D, Xiao J-P, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci 2016; 113: 11907-11912.##Valeriy K, Svetlana M, Ran A, Rina A, Gelareh M, Zenon I, et al. Non-invasive preimplantation genetic testing for aneuploidy (NIPGT-A). Reprod BioMed Online 2019; 38: e41-e42.##Leaver M, Wells D. Non-invasive preimplantation genetic testing (niPGT): The next revolution in reproductive genetics? Hum Reprod Update 2020; 26: 16-42.##De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C. ESHRE PGD consortium data collection XIV-XV: Cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod 2017; 32: 1974-1994.##Montag M, Van der Ven K, Rösing B, Van der Ven H. Polar body biopsy: A viable alternative to preimplantation genetic diagnosis and screening. Reprod Biomed Online 2009; 18 (Suppl.): 6-11.##Piyamongkol W, Bermúdez MG, Harper JC, Wells D. Detailed investigation of factors influencing amplification efficiency and allele drop‐out in single cell PCR: Implications for preimplantation genetic diagnosis. Mol Hum Reprod 2003; 9: 411-420.##Alteri A, Cermisoni GC, Pozzoni M, Gaeta G, Cavoretto PI, Vigano P. Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing. Hum Reprod Update 2023; 29: 291-306.##Kuznyetsov V, Madjunkova S, Abramov R, Antes R, Ibarrientos Z, Motamedi G, et al. Minimally invasive cell-free human embryo aneuploidy testing (miPGT-A) utilizing combined spent embryo culture medium and blastocoel fluid-towards development of a clinical assay. Sci Rep 2020; 10: 7244.##Jiao J, Shi B, Sagnelli M, Yang D, Yao Y, Li W, et al. Minimally invasive preimplantation genetic testing using blastocyst culture medium. Hum Reprod 2019; 34: 1369-1379.##Shitara A, Takahashi K, Goto M, Takahashi H, Iwasawa T, Onodera Y, et al. Cell-free DNA in spent culture medium effectively reflects the chromosomal status of embryos following culturing beyond implantation compared to trophectoderm biopsy. PLoS One 2021; 16: e0246438.##Hammond ER, Shelling AN, Cree LM. Nuclear and mitochondrial DNA in blastocoele fluid and embryo culture medium: Evidence and potential clinical use. Hum Reprod 2016; 31: 1653-1661.##Zhang Y, Li N, Wang L, Sun H, Ma M, Wang H, et al. Molecular analysis of DNA in blastocoele fluid using next-generation sequencing. J Assist Reprod Genet 2016; 33: 637-645.##Bolton H, Graham SJ, Van der Aa N, Kumar P, Theunis K, Fernandez Gallardo E, et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Commun 2016; 7: 11165.##Gombos K, Galik B, Kalacs KI, Godony K, Varnagy A, Alpar D, et al. NGS-based application for routine non-invasive pre-implantation genetic assessment in IVF. Int J Mol Sci 2021; 22: 2443.##Homer HA. Preimplantation genetic testing for aneuploidy (PGT-A): The biology, the technology and the clinical outcomes. Aust N Z J Obstet Gynaecol 2019; 59: 317-324.##Lledo B, Ortiz JA, Morales R, Garcia-Hernandez E, Ten J, Bernabeu A, et al. Comprehensive mitochondrial DNA analysis and IVF outcome. Hum Reprod Open 2018; 2018: hoy023.##Zhang WY, von Versen-Höynck F, Kapphahn KI, Fleischmann RR, Zhao Q, Baker VL. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril 2019; 112: 283-290.##https://doi.org/10.1016/j.fertnstert.2019.07.834##Assou S, Aït-Ahmed O, El Messaoudi S, Thierry AR, Hamamah S. Non-invasive pre-implantation genetic diagnosis of X-linked disorders. Med Hypotheses 2014; 83: 506-508.##Wu H, Ding C, Shen X, Wang J, Li R, Cai B, et al. Medium-based noninvasive preimplantation genetic diagnosis for human α-thalassemias-SEA. Medicine (Baltimore) 2015; 94: e669.##Fang Q, Yuan Z, Hu H, Zhang W, Wang G, Wang X. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection. Clin Epigenetics 2023; 15: 119.##Shamonki MI, Jin H, Haimowitz Z, Liu L. Proof of concept: Preimplantation genetic screening without embryo biopsy through analysis of cell-free DNA in spent embryo culture media. Fertil Steril 2016; 106: 1312-1318.##Hanson BM, Tao X, Hong KH, Comito CE, Pangasnan R, Seli E, et al. Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy. Fertil Steril 2021; 115: 1461-1470.##Rubio C, Navarro-Sanchez L, Garcia-Pascual CM, Ocali O, Cimadomo D, Venier W, et al. Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. Am J Obstet Gynecol 2020; 223: 751.##Farra C, Choucair F, Awwad J. Corrigendum. Non-invasive pre-implantation genetic testing of human embryos: An emerging concept. Hum Reprod 2019; 34: 590.##Biricik A, Cotroneo E, Minasi MG, Greco PF, Bono S, Surdo M, et al. Cross-validation of next-generation sequencing technologies for diagnosis of chromosomal mosaicism and segmental aneuploidies in preimplantation embryos model. Life (Basel) 2021; 11: 340.##Rubio C, Rienzi L, Navarro-Sanchez L, Cimadomo D, Garcia-Pascual CM, Albricci L, et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: Concordance rate and clinical implications. Fertil Steril 2019; 112: 510-519.##Yin B, Zhang H, Xie J, Wei Y, Zhang C, Meng L. Validation of preimplantation genetic tests for aneuploidy (PGT-A) with DNA from spent culture media (SCM): Concordance assessment and implication. Reprod Biol Endocrinol 2021; 19: 41.##Yang L, Shi W, Li Y, Tong J, Xue X, Zhao Z, et al. SCM is potential resource for non-invasive preimplantation genetic testing based on human embryos single-cell sequencing. Gene 2023; 882: 147647.##Xu J, Fang R, Chen L, Chen D, Xiao JP, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci U S A 2016; 113: 11907-11912.##Huang J, Rong L, Zeng L, Hu L, Shi J, Cai L, et al. Embryo selection through non-invasive preimplantation genetic testing with cell-free DNA in spent culture media: A protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open 2022; 12: e057254.##Yeung QSY, Zhang YX, Chung JPW, Lui WT, Kwok YKY, Gui B, et al. A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM). J Assist Reprod Genet 2019; 36: 1609-1621.##Chen D, Xu Y, Ding C, Wang Y, Fu Y, Cai B, et al. The inconsistency between two major aneuploidy-screening platforms-single-nucleotide polymorphism array and next-generation sequencing-in the detection of embryo mosaicism. BMC Genomics 2022; 23: 62.##Brouillet S, Martinez G, Coutton C, Hamamah S. Is cell-free DNA in spent embryo culture medium an alternative to embryo biopsy for preimplantation genetic testing? A systematic review. Reprod Biomed Online 2020; 40: 779-796.##Tsai NC, Chang YC, Su YR, Lin YC, Weng PL, Cheng YH, et al. Validation of non-invasive preimplantation genetic screening using a routine IVF laboratory workflow. Biomedicines 2022; 10: 1386.##Xu Z, Pan W. Binomial mixture model based association testing to account for genetic heterogeneity for GWAS. Genet Epidemiol 2016; 40: 202-209.##Feichtinger M, Vaccari E, Carli L, Wallner E, Madel U, Figl K, et al. Non-invasive preimplantation genetic screening using array comparative genomic hybridization on spent culture media: A proof-of-concept pilot study. Reprod Biomed Online 2017; 34: 583-589.##Vera-Rodriguez M, Rubio C. Assessing the true incidence of mosaicism in preimplantation embryos. Fertil Steril 2017; 107: 1107-1112.##Liu YL, Yu TN, Wang PH, Tzeng CR, Chen CH, Chen CH. Could PGT-A pick up true abnormalities that have clinical relevance? Retrospective analysis of 1043 embryos. Taiwan J Obstet Gynecol 2020; 59: 496-501.##Ho JR, Arrach N, Rhodes-Long K, Ahmady A, Ingles S, Chung K, et al. Pushing the limits of detection: Investigation of cell-free DNA for aneuploidy screening in embryos. Fertil Steril 2018; 110: 467-475.##Cinnioglu C, Glessner H, Jordan A, Bunshaft S. A systematic review of noninvasive preimplantation genetic testing for aneuploidy. Fertil Steril 2023; 120: 235-239.##Lane M, Zander-Fox D, Hamilton H, Jasper M, Hodgson B, Fraser M, et al. Ability to detect aneuploidy from cell free DNA collected from media is dependent on the stage of development of the embryo. Fertil Steril 2017; 108 (Suppl.): e61.##Huang J, Yao Y, Jia J, Zhu X, Ma J, Wang J, et al. Chromosome screening of human preimplantation embryos by using spent culture medium: Sample collection and chromosomal ploidy analysis. J Vis Exp 2021; 175: e62619.##Zong C, Lu S, Chapman AR, Xie XS. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012; 338: 1622-1626.##Tomic M, Vrtacnik Bokal E, Stimpfel M. Non-invasive preimplantation genetic testing for aneuploidy and the mystery of genetic material: A review article. Int J Mol Sci 2022; 23: 3568.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The categorization of opaque pathologies outside of contrast media in hysterosalpingography which facilitate interpretation: A pictorial review</TitleF>
		<TitleE>طبقه بندی پاتولوژی های دنس خارج از نواحی حاجب در هیستروسالپینگوگرافی که تفسیر را تسهیل می کند: یک بررسی تصویری</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>عکس رنگی رحم یا هیستروسالپینگوگرافی (HSG) یک روش تصویربرداری کاربردی و قابل اعتمادی است که برای بررسی کانال سرویکال، کاویته رحم و لوله&#173;های فالوپ می&#173;باشد. با استفاده از HSG پاتولوژی&#173;های نواحی حاجب شده و نواحی غیر&#173;حاجب که اوپاک باشند، قابل بررسی می&#173;باشد. هدف ما از این مقاله تقسیم&#173;بندی یافته&#173;های پاتولوژیک اوپاک خارج از نواحی حاجب شده در HSG است. در این مقاله تصاویر جالب و نسبتاً غیر&#173;شایع از پاتولوژی&#173;های خارج از منطقه حاجب در HSG که توسط آقای دکتر شهرزاد در طی 50 سال گردآوری گردیده، ارائه شده است. در کلیشه ساده لگن، بافت نرم، ساختمان&#173;های استخوانی، آرتیفکت&#173;ها یا جسم خارجی دیده می&#173;شوند. تقسیم&#173;بندی پاتولوژی&#173;ها می&#173;تواند به متخصصین رادیولوژی در تفسیر صحیح HSG کمک نماید. پاتولوژی&#173;های اوپاک خارج از نواحی حاجب شده در HSG به دو گروه پاتولوژی&#173;های وابسته به بافت&#173;های داخل لگنی و اجسام خارجی تقسیم شدند. اجسام خارجی ممکن است در داخل بدن و یا در خارج از بدن قرار گرفته باشند. آشنایی با پاتولوژی&#173;های بافت&#173;های لگن و تفسیر دقیق تصاویر HSG ضروری است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Hysterosalpingography (HSG) is a practical and reliable imaging method to evaluate the cervical canal, uterine isthmus, uterine cavity, and fallopian tubes. Using HSG, opaque pathologies outside of contrast media can be detected as well as pathologies of uterus and fallopian tubes. We aim to present and categorize some uncommon and interesting abnormal findings that are located outside of the contrast areas in HSG. This is a pictorial review that depicts various types of HSG images that include opaque pathologies outside of the contrast areas. Images have been extracted from valuable archives collected over 50 yr by professor Shahrzad. A plain pelvic film contains soft tissues of the pelvis, bony structures, artifacts, or foreign bodies. Categorization might easily help the radiologist to interpret the HSG clich&#233;. Opaque pathologies outside of contrast area in HSG can be categorized into 2 groups: &#8220;Pelvic Tissue Related&#8221; and &#8220;Foreign Bodies&#8221;. Pelvic tissue abnormalities might have a gynecologic or non-gynecologic source. Foreign bodies can be located in the pelvis or outside of the body. HSG is a reliable and inexpensive procedure. Familiarity with the pathologies of pelvic tissues and the accurate interpretation of HSG images are important.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>191</FPAGE>
			<TPAGE>202</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/29
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/8/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/11
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/21
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Fereshteh</Name>
				<MidName></MidName>
				<Family>Hosseini</Family>
				<NameE>Fereshteh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosseini</FamilyE>
				<Organizations>
				<Organization>Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hosseini.f1346@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fattaneh</Name>
				<MidName></MidName>
				<Family>Pahlavan</Family>
				<NameE>Fattaneh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Pahlavan</FamilyE>
				<Organizations>
				<Organization>Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>midwiferesfahan@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Firoozeh</Name>
				<MidName></MidName>
				<Family>Ahmadi</Family>
				<NameE>Firoozeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahmadi</FamilyE>
				<Organizations>
				<Organization>Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.ahmadi1390@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hysterosalpingography</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Opaque</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Abnormalities</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Uterine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Fallopian tubes.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیستروسالپینگوگرافی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اوپاک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ناهنجاری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رحم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لوله های فالوپ.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Luczynska E, Zbigniew K. Diagnostic imaging in gynecology. Ginekol Pol 2022; 93: 63-69.##Baușic A, Coroleucă C, Coroleucă C, Comandașu D, Matasariu R, Manu A, et al. Transvaginal ultrasound vs. magnetic resonance imaging (MRI) value in endometriosis diagnosis. Diagnostics 2022; 12: 1767.##Gündüz R, Ağaçayak E, Okutucu G, Karuserci ÖK, Peker N, Çetinçakmak MG, et al. Hysterosalpingography: A potential alternative to laparoscopy in the evaluation of tubal obstruction in infertile patients? Afr Health Sci 2021; 21: 373-378.##Panda SR, Kalpana BJC. The diagnostic value of hysterosalpingography and hysterolaparoscopy for evaluating uterine cavity and tubal patency in infertile patients. Cureus 2021; 13: e12526.##Martí-Bonmatí L. Hysterosalpingography and fertility: A technical relationship. Fertil Steril 2018; 110: 642.##Shaaban AM, Rezvani M, Olpin JD, Kennedy AM, Gaballah AH, Foster BR, et al. Nongynecologic findings seen at pelvic US. Radiographics 2017; 37: 2045-2062.##Zulfiqar M, Shetty A, Tsai R, Gagnon M-H, Balfe DM, Mellnick VM. Diagnostic approach to benign and malignant calcifications in the abdomen and pelvis. Radiographics 2020; 40: 731-753.##Heursen EM, González Partida MD, Paz Expósito J, Navarro Díaz F. Osteomesopyknosis-a benign axial hyperostosis that can mimic metastatic disease. Skeletal Radiol 2016; 45: 141-146.##Ahmadi F, Hosseini F, Javam M, Pahlavan F. Hysterosalpingography findings of leiomyomas and how they look in artistic eyes: New diagnostic signs. Br J Radiol 2021; 94: 20200019.##Taborda F, Fernandes B, Lobão MJ. Calcified uterine myoma: An infrequent radiologic finding. Lusiadas Sci J 2021; 2: 82-83.##Zhu M, Li J, Duan J, Yang J, Gu W, Jiang W. Bilateral ovarian fibromas as the sole manifestation of Gorlin syndrome in a 22-year-old woman: A case report and literature review. Diagn Pathol 2023; 18: 118.##Ahmadi F, Zafarani F, Shahrzad G. Hysterosalpingographic appearances of female genital tract tuberculosis: Part I. fallopian tube. Int J Fertil Steril 2014; 7: 245-252.##Siddiqui E. Calcifications. In: Eltorai AEM, Hyman C-H, Healey TT. Essential radiology review. USA: Springer; 2019. 277-278.##Ladumor H, Al-Mohannadi S, Ameerudeen FS, Ladumor S, Fadl S. TB or not TB: A comprehensive review of imaging manifestations of abdominal tuberculosis and its mimics. Clin Imaging 2021; 76: 130-143.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of aqueous extract of orchid root on the structure of ovary and hypothalamic-pituitary-gonadal hormones in polycystic ovary syndrome rat model: An experimental study</TitleF>
		<TitleE>تأثیر عصاره آبی ریشه ارکیده بر ساختار تخمدان و هورمون‌های هیپوتالاموس-هیپوفیز-گناد در موش های صحرایی مبتلا به سندرم تخمدان پلی کیستیک: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: برخی از شرایط پزشکی، از جمله سندرم تخمدان پلی&#173;کیستیک (PCOs)، ممکن است منجر به ناباروری شود. عدم تعادل هورمونی در PCOs قابل توجه است. آنتی&#173;اکسیدان&#173;های طبیعی دارای مزایای سلامتی بسیاری از جمله اثرات مثبت بر تولید هورمون هستند.
هدف: از آنجایی که داروهای گیاهی برای بیماران ایمن&#8204;تر و قابل قبول&#8204;تر هستند، مطالعه حاضر به منظور بررسی اثر عصاره آبی ارکیده (SA) با اثرات آنتی&#173;اکسیدانی بر ساختار تخمدان و هورمون&#8204;های محور هیپوتالاموس-هیپوفیز-گناد و تستوسترون آزاد در موش&#8204;های صحرایی PCO طراحی شد.
مواد و روش&#173; ها: در این مطالعه تجربی، 64 موش صحرایی ماده سالم ویستار (180-200 گرم) به&#8204;طور تصادفی به گروه&#8204;های کنترل 60 و 89 روزه، گروه PCOs و 4 گروه PCO+ SA با دوزهای 40، 80، 160 و 320 میلی&#8204;گرم بر کیلوگرم SA تقسیم شدند. سطوح سرمی GnRH، استروژن، پروژسترون، تستوسترون، هورمون محرک فولیکول و هورمون لوتئینیزه&#173;کننده اندازه&#173;گیری شد. علاوه بر این، تخمدان&#173;ها استخراج و مورد بررسی بافت&#173;شناسی قرار گرفتند. 
نتایج: میزان فولیکول&#8204;های نخستین، اولیه، ثانویه و گراف و سطوح سرمی هورمون&#8204;های FSH و پروژسترون در گروه&#8204;های PCO کاهش یافت، در حالی که فولیکول&#8204;های آترتیک و سطوح سرمی GnRH، هورمون محرک فولیکول، استروژن و تستوسترون آزاد افزایش داشت. استفاده از دوزهای مختلف SA عدم تعادل هورمونی و بافتی ناشی از PCO را تنظیم کرد که 320 میلی&#8204;گرم بر کیلوگرم مؤثرترین دوز بود.
نتیجه &#173;گیری: عصاره آبی ریشه ارکیده می&#8204;تواند تأثیر مثبتی در بهبود PCOs داشته باشد. این اثر را می&#8204;توان با تنظیم سطح هورمون&#8204;های جنسی و اصلاح ناهنجاری&#173;های فولیکولی در بافت تخمدان به دست آورد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Some medical conditions, including polycystic ovarian syndrome (PCOs), may lead to infertility. In PCOs, hormonal imbalance is significant. Antioxidants such as natural antioxidants have many health benefits, including positive effects on hormone production.
Objective: Since herbal medicines are more acceptable to people, the present study was designed to evaluate the effect of an aqueous extract of orchid (SA), with antioxidative effects, on the structure of the ovary and the hypothalamic-pituitary-gonadal axis hormones and free testosterone in PCOs rats.
Materials and Methods: In this experimental study, 64 healthy female Wistar rats (180-200 gr) were randomly divided into 60 and 89 day control groups, PCOs, and 4 PCOs + SA groups that received 40, 80, 160, and 320 mg/kg of SA. Serum levels of gonadotropin-releasing hormone, estrogen, progesterone, testosterone, follicle-stimulating hormone, and luteinizing hormone were measured. In addition, the ovaries were extracted and examined histologically.
Results: The amount of primordial, primary, secondary, and Graafian follicles and serum levels of follicle-stimulating hormone and progesterone hormones decreased in PCOs groups, while atretic follicles and the serum levels of gonadotropin-releasing hormone, luteinizing hormone, estrogen, and free testosterone were increased. SA at different doses regulated hormonal and histological imbalances caused by PCOs, and 320 mg/kg was the most effective.
Conclusion: The aqueous extract of orchids root can have a positive effect on the improvement of polycystic ovary syndrome. This effect can be achieved by regulating the level of sex hormones and correcting follicular abnormalities in the ovarian tissue.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>203</FPAGE>
			<TPAGE>210</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/19
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/4/28
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/24
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/5
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Hassanali</Name>
				<MidName></MidName>
				<Family>Abedi</Family>
				<NameE>Hassanali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abedi</FamilyE>
				<Organizations>
				<Organization>Research Center for Noncommunicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hassanaliabedi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Armin</Name>
				<MidName></MidName>
				<Family>Zarrin-Mehr</Family>
				<NameE>Armin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zarrin-Mehr</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>A.Z.9303@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Bahareh</Name>
				<MidName></MidName>
				<Family>Ebrahimi</Family>
				<NameE>Bahareh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebrahimi</FamilyE>
				<Organizations>
				<Organization>Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>ebrahimi_b@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hoda</Name>
				<MidName></MidName>
				<Family>Haghshenas</Family>
				<NameE>Hoda</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haghshenas</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hoda76h@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Negar</Name>
				<MidName></MidName>
				<Family>Parvin</Family>
				<NameE>Negar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Parvin</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>n.parvin98@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hossein</Name>
				<MidName></MidName>
				<Family>Kargar Jahromi</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kargar Jahromi</FamilyE>
				<Organizations>
				<Organization>Research Center for Noncommunicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>h.kargar@jums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>PCOS</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Orchid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovary</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GnRH</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>LH</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>FSH.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>PCOs</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ارکیده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GnRH</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>LH</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>FSH.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Bachanek M, Abdalla N, Cendrowski K, Sawicki W. Value of ultrasonography in the diagnosis of polycystic ovary syndrome-literature review. J Ultrason 2015; 15: 410-422.##Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, et al. Polycystic ovary syndrome: A "risk-enhancing" factor for cardiovascular disease. Fertil Steril 2022; 117: 924-935.##Pfieffer ML. Polycystic ovary syndrome: An update. Nursing 2019; 49: 34-40.##Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): A review of literature. J Healthc Eng 2022; 2022: 9240569.##Al Wattar BH, Fisher M, Bevington L, Talaulikar V, Davies M, Conway G, et al. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: A systematic review and quality assessment study. J Clin Endocrinol Metab 2021; 106: 2436-2446.##Moran LJ, Tassone EC, Boyle J, Brennan L, Harrison CL, Hirschberg AL, et al. Evidence summaries and recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management. Obes Rev 2020; 21: e13046.##Khashchenko E, Vysokikh M, Uvarova E, Krechetova L, Vtorushina V, Ivanets T, et al. Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight. J Clin Med 2020; 9: 1399.##Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci 2019; 62: 335-343.##Kargar Jahromi H, Solhjoo E, Hassannezhad A, Pourahmadi M, Sahraei R, Abedi H, et al. [Comparison of aqueous extract of Salepâ s root (Dactylorhiza maculate) with ibuprofen on pain sensory thresholds using the formalin test in adult male rats]. Pars J Med Sci 2022; 18: 15-22. (in Persian)##Easley T, Horne S. The modern herbal dispensatory: A medicine-making guide. US: North Atlantic Books; 2016.##Sadeghzadeh F, Sadeghzadeh A, Changizi-Ashtiyani S, Alimoradian A, Mashayekhei M, Zarei A, et al. The effects of hydro-alcoholic extracts of Allium sativum L. and Orchismaculata L. on spermatogenesis index and testosterone level in cyclophosphamide-treated rats. J Kerman Univ Med Sci 2020; 27: 232-243.##Guadarrama-Bazante IL, Rodríguez-Manzo G. Nucleus accumbens dopamine increases sexual motivation in sexually satiated male rats. Psychopharmacology 2019; 236: 1303-1312.##Solhjo K, Kargar Jahromi H, Solhjo KA, Khabbaz Kherameh Z, Mahdiyar M. The effect of the aqueous extract of orchid roots on the serum concentration of progesterone and luteinizing hormone in adult female rats. Pars J Med Sci 2015; 13: 21-26.##Abu Ahmed AM, Rahman A, Hossen A, Ali Reza ASM, Islam Sh, Rashid M, et al. Epiphytic acampe ochracea orchid relieves paracetamol-induced hepatotoxicity by inhibiting oxidative stress and upregulating antioxidant genes in in vivo and virtual screening. Biomed Pharmacother 2021; 143: 112215.##Barragán-Zarate GS, Lagunez-Rivera L, Solano R, Pineda-Peña EA, Landa-Juárez AY, Chávez-Piña AE, et al. Prosthechea karwinskii, an orchid used as traditional medicine, exerts anti-inflammatory activity and inhibits ROS. J Ethnopharmacol 2020; 253: 112632.##Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Soltanghoraee H. Polycystic ovary morphology (PCOM) in estradiol valerate treated mouse model. Int J Women's Health Reprod Sci 2016; 4: 13-17.##Venegas B, De León Gordillo LY, Rosas G, Espinoza JA, Morán C, Domínguez R, et al. In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation. Reprod Biol Endocrinol 2019; 17: 95.##Atashpour Sh, Abedi H, Shafiei Jahromi N, Bagherzadeh MA, Saremi J, Mahjour A, et al. The effect of Salep Aqueous extract high doses on serum level of urea nitrogen, creatinine, uric acid and kidney histopathological changes in adult male wistar rats. Arch Razi Inst 2023; 78: 1451-1461.##Kargar Jahromi H, Pourahmad M, Abedi HA, Karimi M, Kargar Jahromi Z. Protective effects of salep against isoniazid liver toxicity in wistar rats. J Tradit Complement Med 2018; 8: 239-243.##Kargar Jahromi H, Khorram A, Atashpoor Sh, Jalali M, Kargar Jahromi Z, Mohammadi F, et al. The effect of hydroalcoholic extract of Salep on pentylenetetrazole-Iinduced seizure in adult male rats. Iran J Neurosurg 2023; 9: 1-9.##Chauhan NS, Sharma V, Dixit VK, Thakur M. A review on plants used for improvement of sexual performance and virility. Biomed Res Int 2014; 2014: 868062.##Lakshmi JN, Babu AN, Kiran SS, Nori LP, Hassan N, Ashames A, et al. Herbs as a source for the treatment of polycystic ovarian syndrome: A systematic review. BioTech 2023; 12: 4.##Shahzad H, Giribabu N, Muniandy S, Salleh N. Quercetin induces morphological and proliferative changes of rat's uteri under estrogen and progesterone influences. Int J Clin Exp Pathol 2014; 7: 5484.##Han B, Jiang P, Jiang L, Li X, Ye X. Three phytosterols from sweet potato inhibit MCF7-xenograft-tumor growth through modulating gut microbiota homeostasis and SCFAs secretion. Food Res Int 2021; 141: 110147.##Matsuda F, Ohkura S, Magata F, Munetomo A, Chen J, Sato M, et al. Role of kisspeptin neurons as a GnRH surge generator: Comparative aspects in rodents and non‐rodent mammals. J Obstet Gynaecol Res 2019; 45: 2318-2329.##Watanabe M, Fukuda A, Nabekura J. The role of GABA in the regulation of GnRH neurons. Front Neurosci 2014; 8: 387.##Hajiani M, Kargar Jahromi H, Kargar Jahromi Z, Khabbaz Kherameh Z. [Study on the effect of 4-weeks treatment of the aqueous extract of the roots of Salep plants on the serum concentration of leptin hormone and body weight in male rats]. J Jahrom Univ Med Sci 2014; 12: 9-14. (in Persian)##Childs GV, Odle AK, MacNicol MC, MacNicol AM. The importance of leptin to reproduction. Endocrinology 2021; 162: bqaa204.##Afradiasbagharani P, Hosseini E, Allahveisi A, Bazrafkan M. The insulin-like growth factor and its players: Their functions, significance, and consequences in all aspects of ovarian physiology. Middle East Fertil Soc J 2022; 27: 27.##Li H, Yu X, Meng F, Zhao Z, Guan S, Wang L. Ferulic acid supplementation increases lifespan and stress resistance via insulin/IGF-1 signaling pathway in C. elegans. Int J Mol Sci 2021; 22: 4279.##Sgrò P, Ceci R, Lista M, Patrizio F, Sabatini S, Felici F, et al. Quercetin modulates IGF-I and IGF-II levels after eccentric exercise-induced muscle-damage: A placebo-controlled study. Front Endocrinol 2021; 12: 745959.##Jahan S, Abid A, Khalid S, Afsar T, Shaheen G, Almajwal A, et al. Therapeutic potentials of quercetin in management of polycystic ovarian syndrome using letrozole induced rat model: A histological and a biochemical study. J Ovarian Res 2018; 11: 26.##Du J, Ruan X, Jin F, Li Y, Cheng J, Gu M, et al. Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome. J Ovarian Res 2021; 14: 36.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Letrozole and ovarian hyperstimulation syndrome: Retrospective cross-sectional study</TitleF>
		<TitleE>لتروزول و سندرم تحریک بیش از حد تخمدان: یک مطالعه مقطعی گذشته نگر</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: اخیرا لتروزول به علت اثر کاهش&#173;دهنده استروژن و افزایش&#173;دهنده آندروژن بر تخمدان&#173;ها و در نتیجه اثر بر سلول&#173;های گرانولوزا و کاهش تولید فاکتور رشد اندوتلیال عروقی (VEGF) در پیشگیری از سندرم تحریک بیش از حد تخمدان (OHSS) متوسط تا شدید در تکنولوژی کمک باروری (ART) مورد توجه واقع شده است.
هدف: هدف ما از این مطالعه بررسی اثر مصرف لتروزول در پیشگیری از بروز OHSS در زنان نابارور با تشخیص سندرم تخمدان پلی&#173;کیستیک در سیکل ART می&#173;باشد.
مواد و روش &#173;ها: در این مطالعه مقطعی، از بین 1743 پرونده پزشکی زنان نابارور که در برنامه برگشت تخمک مرکز تحقیقاتی درمانی ناباروری یزد قرار داشتند، اطلاعات 343 زن مبتلا به سندرم تخمدان پلی&#173;کیستیک و در معرض خطر OHSS از فروردین تا اسفند 1401 بررسی شد. تحریک تخمدان با پروتکل GnRH آنتاگونیست انعطاف&#173;پذیر انجام شده بود. بیماران براساس دریافت یا عدم دریافت لتروزول به دو گروه تقسم شدند. در گروه لتروزول از روز تریگر 5/2 میلی&#173;گرم لتروزول دوبار در روز ادامه یافت و گروه کنترل لتروزول دریافت نکرد. متغیر&#173;های شدت OHSS و میزان بستری شدن و نیاز به تجویز آلبومین بین دو گروه آنالیز شد.
نتایج: 89 زن در گروه لتروزول و 254 زن در گروه کنترل بررسی شد. از نظر سن و وزن، بین دو گروه اختلاف آماری معنی&#173;داری وجود نداشت ولی از نظر AMH گروه لتروزول AMH بالاتری از لحاظ آماری نسبت به گروه کنترل داشت (61/4 &#177; 53/7 در برابر 63/3 &#177; 47/5 و 001/0 &#60; p). از نظر پارامترهای شدت OHSS و میزان بستری شدن و نیاز به تجویز آلبومین بین دو گروه تفاوت معنی&#173;دار آماری وجود نداشت.
نتیجه &#173;گیری: بر اساس مطالعه اخیر، اضافه کردن لتروزول به درمان GnRH آنتاگونیست و کابرگولین، باعث کاهش شدت OHSS نمی&#173;شود.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Recently, letrozole has been used to prevent moderate to severe ovarian hyperstimulation syndrome (OHSS) in assisted reproductive technology cycles due to its estrogen-reducing and androgen-increasing effects on the ovaries, affecting granulosa cells, and reducing vascular endothelial growth factor production.
Objective: This study aimed to investigate the impact of letrozole consumption in preventing OHSS in infertile women with polycystic ovarian syndrome undergoing in vitro fertilization.
Materials and Methods: In this cross-sectional study, among 1743 medical records of infertile women who were scheduled for oocyte retrieval at Research and Clinical Center for Infertility, Yazd, Iran. Data of 343 women with polycystic ovarian syndrome diagnosis and at risk of OHSS was extracted from March 2022-2023. The stimulation was carried out using a flexible gonadotropin releasing hormone antagonist protocol. Women were divided into 2 groups based on whether they received letrozole or not. In the letrozole group, 2.5 mg letrozole twice daily was continued from the trigger day, while in the control group, women did not receive letrozole. The parameters of OHSS severity, hospitalization rates, and the need for albumin prescription were analyzed. 
Results: 89 women in the letrozole and 254 women in the control group were examined. There was no statistically significant difference between groups in terms of age and body mass index; however, anti-Mullerian hormone was significantly higher than control group (7.53 &#177; 4.61 vs. 5.47 &#177; 3.63, p &#60; 0.001). The parameters of OHSS severity, hospitalization rates, and the need for albumin prescription showed no significant differences between the groups.
Conclusion: Recent study indicates that incorporating letrozole into the treatment of gonadotropinreleasing hormone antagonists and cabergoline does not reduce the OHSS severity.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>211</FPAGE>
			<TPAGE>218</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/192023/12/30
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/10/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/242024/02/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/9
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Elham</Name>
				<MidName></MidName>
				<Family>Nikfarjam</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nikfarjam</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>elhamnikfarjam2022@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Eftekhar</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Eftekhar</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>eftekharmaryam1351@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hanieh</Name>
				<MidName></MidName>
				<Family>Fatehi</Family>
				<NameE>Hanieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fatehi</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.fatehi435@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sahereh</Name>
				<MidName></MidName>
				<Family>Arabian</Family>
				<NameE>Sahereh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Arabian</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Research Center for Abnormal Uterine Bleeding, Semnan University of Medical Sciences, Semnan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>sahereh_arabian@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Letrozole</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Polycystic ovary syndrome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovarian hyperstimulation syndrome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Assisted reproductive technologies.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لتروزول</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سندرم تخمدان پلی کیستیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سندرم تحریک بیش از حد تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تکنولوژی کمک باروری</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Du D-F, Li M-F, Li X-L. Ovarian hyperstimulation syndrome: A clinical retrospective study on 565 inpatients. Gynecol Endocrinol 2020; 36: 313-317.##Palomba S, Costanzi F, Nelson SM, Caserta D, Humaidan P. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: A systematic umbrella review of the best clinical evidence. Reprod Biol Endocrinol 2023; 21: 67.##Choudhary RA, Vora PH, Darade KK, Pandey S, Ganla KN. A prospective randomised comparative clinical trial study of luteal phase letrozole versus ganirelix acetate administration to prevent severity of early onset OHSS in ARTs. Int J Fertil Steril 2021; 15: 263-268.##Di Guardo F, Lello Ch, Incognito GG, Bruno MT, Palumbo M. Letrozole and ovarian hyperstimulation syndrome (OHSS): A promising prevention strategy. J Clin Med 2023; 12: 614.##Namvar Jahromi B, Parsanezhad ME, Shomali Z, Bakhshai P, Alborzi M, Moin Vaziri N, et al. Ovarian hyperstimulation syndrome: A narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran J Med Sci 2018; 43: 248-260.##Pellicer N, Pellicer A. Pathogenesis and management in OHSS. In: Dahan MH, Fatemi HM, Polyzos NP, Garcia-Velasco JA. Handbook of current and novel protocols for the treatment of infertility. UK: Academic Press, Elsevier; 2024.##El-Khayat W, Elsadek M. Calcium infusion for the prevention of ovarian hyperstimulation syndrome: A double-blind randomized controlled trial. Fertil Steril 2015; 103: 101-105.##Zhang Q, Ma Y, Bu X, Jia C, Liu Y, Wang S. Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome. Int J Gynecol Obstet 2022; 159: 944-950.##Zhao J, Xu B, Huang X, Yan Y, Li Y. Whether letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis. Reprod Health 2020; 17: 181.##Attalla W, Abd Elhamidb T. Aromatase inhibitors versus cabergoline for the prevention of ovarian hyperstimulation syndrome: A prospective, randomized, double-blind study. Evid Based Women's Health J 2017; 7: 22-29.##Agarwal S, Krishna D, Rao KA. Prevention and management of ovarian hyperstimulation syndrome. Int J Infertil Fetal Med 2019; 10: 46-51.##Minami T, Yamana H, Shigemi D, Matsui H, Fushimi K, Yasunaga H. Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study. Int J Reprod BioMed 2019; 17: 709.##Fouda UM, Elshaer HS, Youssef GG, Hanafy A, Mehrem WM, Youssef MA, et al. Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: A randomised controlled study. J Obstet Gynaecol 2022; 42: 122-126.##Mohammadi Yeganeh L, Moini A, Shiva M, Mirghavam N, Bagheri Lankarani N. Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: A randomised controlled trial. J Obstet Gynaecol 2018; 38: 241-246.##Eftekhar M, Saeed L. Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT. Int J Reprod BioMed 2020; 18: 287-294.##Mangal S. Current knowledge on the use of letrozole in ovarian stimulation. Int J Infertil Fetal Med 2021; 11: 48-53.##Qi Q, Xia Y, Luo J, Wang Y, Xie Q. Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: A prospective randomized trial. Gynecol Endocrinol 2023; 39: 2269281.##Chen Y, Yang T, Hao C, Zhao J. A retrospective study of letrozole treatment prior to human chorionic gonadotropin in women with polycystic ovary syndrome undergoing in vitro fertilization at risk of ovarian hyperstimulation syndrome. Med Sci Monit 2018; 24: 4248-4253.##Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.##Yanagihara Y, Tanaka A, Nagayoshi M, Tanaka I, Ohno M, Itakura A. Combined use of letrozole, cabergoline and GnRH antagonist eliminates ovarian hyperstimulation syndrome (OHSS) in polycystic ovarian syndrome (PCOS). Evid Based Women's Health J 2022; 12: 262-269.##Ghasemi Tehrani H, Aasasi K, Mardanian F, Mehrabian F, Movahedi M, Naghshineh E. Evaluation of the effect of letrozole in the ovarian hyperstimulation syndrome prevention in participants at risk of treatment with ovulation-stimulating drugs: A randomized controlled trial. Rep Biochem Mol Biol 2022; 11: 386-393.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Naringenin ameliorates cytotoxic effects of bisphenol A on mouse Sertoli cells by suppressing oxidative stress and modulating mitophagy: An experimental study</TitleF>
		<TitleE>بهبود اثرات سیتوتوکسیک بیسفنل آ بر سلول های سرتولی موش کوچک آزمایشگاهی بوسیله نارینجنین با سرکوب استرس اکسیداتیو و تعدیل میتوفاژی: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: بیسفنل آ (BPA)، یک عامل مختل&#173;کننده سیستم درون&#173;ریز، به طور گسترده&#173;ای به عنوان پلاستیک&#173;های پلی&#173;کربنات برای تولید ظروف مواد غذایی استفاده می&#173;شود. قرار گرفتن در معرض BPA در غلظت&#173;های موجود در محیط زیست می&#173;تواند باعث اختلالات تولید&#173;مثل شود.
هدف: اثر نارینجنین (NG) بر سمیت سلولی ایجاد شده در سلول&#173;های سرتولی (رده سلولی TM4) ناشی از BPA و مکانیسم آن در مطالعه حاضر مورد بررسی قرار گرفت.
مواد و روش&#173;ها: در مطالعه تجربی-آزمایشگاهی حاضر، سلول&#173;ها به مدت 24 ساعت با BPA (8/0 میکرومولار) یا NG در دوزهای 10، 20 و 50 میکروگرم در میلی&#173;لیتر تیمار شدند. میزان زنده ماندن سلول&#173;ها، تولید رادیکال&#173;های آزاد اکسیژن (ROS)، محتوای مالون&#173;دی&#173;&#8204;آلدئید (MDA)، سطح آنتی&#173;اکسیدان&#8204;ها و پتانسیل غشای میتوکندری (MMP) سنجیده شد. بیان ژن&#8204;های مرتبط با میتوفاژی، از جمله Parkin و Pink1 نیز مورد ارزیابی قرار گرفت.
نتایج: BPA به طور قابل توجهی زنده ماندن سلول&#173;های سرتولی را کاهش داد (004/0 = p). سطوح Pink1 و Parkin در گروه BPA به طور قابل توجهی افزایش یافت (001/0 &#60; p)، در حالی که MMP به طور قابل توجهی کاهش یافت (001/0 &#60; p). BPA، سطح MDA و ROS را افزایش داد (001/0 &#60; p) و مارکرهای آنتی&#173;اکسیدانی را کاهش داد (003/0 = p). NG در غلظت&#173;های 20 و 50 میکروگرم در میلی&#173;لیتر می&#173;تواند به طور قابل توجهی زنده ماندنی و MMP سلول&#173;های TM4 را افزایش دهد (034/0 = p). درمان با NG به غلظت بستگی دارد و می&#173;تواند سطوح Pink1 و Parkin را در مقایسه با گروه BPA کاهش دهد (024/0 = p). NG فاکتورهای آنتی&#173;اکسیدانی را افزایش داد، در حالی که سطوح ROS و MDA در سلول&#173;های در معرض BPA کاهش یافت.
نتیجه&#173;گیری: &#160;اثرات مفید NG بر سلول&#8204;های سرتولی در معرض BPA با سرکوب میتوفاژی و کاهش استرس اکسیداتیو مرتبط است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Bisphenol A (BPA), an endocrine-disrupting agent, is widely used as polycarbonate plastics for producing food containers. BPA exposure at environmentally relevant concentrations can cause reproductive disorders. 
Objective: The effect of Naringenin (NG) on BPA-induced Sertoli cell toxicity and its mechanism was examined in the present study. 
Materials and Methods: In this experimental-laboratory study, the mouse TM4 cells were treated to BPA (0.8 &#956;M) or NG for 24 hr at concentrations of 10, 20, and 50 &#956;g/ml. Cell viability, reactive oxygen species (ROS) production, malondialdehyde (MDA) content, antioxidant level, and mitochondrial membrane potential (MMP) were examined. The expression of mitophagy-related genes, including Parkin and PTEN-induced putative kinase 1 (Pink1), was also evaluated. 
Results: BPA significantly lowered the viability of the Sertoli cells (p = 0.004). Pink1 and Parkin levels of the BPA group were significantly increased (p &#60; 0.001), while the MMP was considerably decreased (p &#60; 0.001). BPA raised MDA and ROS levels (p &#60; 0.001) and reduced antioxidant biomarkers (p = 0.003). NG at the 20 and 50 &#956;g/ml concentrations could significantly improve the viability and MMP of TM4 cells (p = 0.034). NG depending on concentration, could decrease Pink1 and Parkin at mRNA and protein levels compared to the BPA group (p = 0.024). NG enhanced antioxidant factors, while ROS and MDA levels were decreased in the BPA-exposed cells. 
Conclusion: The beneficial impacts of NG on BPA-exposed Sertoli cells are related to the suppression of mitophagy and the reduction of oxidative stress.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>219</FPAGE>
			<TPAGE>228</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/192023/12/302023/11/11
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/8/20
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/242024/02/282024/03/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/15
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Layasadat</Name>
				<MidName></MidName>
				<Family>Khorsandi</Family>
				<NameE>Layasadat</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khorsandi</FamilyE>
				<Organizations>
				<Organization>Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>khorsandi_cmrc@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>abbas</Name>
				<MidName></MidName>
				<Family>Heidari-Moghadam</Family>
				<NameE>abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Heidari-Moghadam</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>abbass.heidari@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Elham</Name>
				<MidName></MidName>
				<Family>Younesi</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Younesi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>elhamyounesi29@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad-Javad</Name>
				<MidName></MidName>
				<Family>Khodayar</Family>
				<NameE>Mohammad-Javad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khodayar</FamilyE>
				<Organizations>
				<Organization>Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>khodayar-mj@ajums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Yousef</Name>
				<MidName></MidName>
				<Family>Asadi-Fard</Family>
				<NameE>Yousef</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asadi-Fard</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, School of Medicine, Arak University of Medical Sciences, Arak, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>usef.fard@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Mitophagy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Naringenin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sertoli cells</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Bisphenol A</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Reactive oxygen species</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pink1</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Parkin.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>میتوفاژی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نارینجنین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلول های سرتولی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیسفنل آ</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>گونه های فعال اکسیژن</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pink1</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Parkin</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Manzoor MF, Tariq T, Fatima B, Sahar A, Tariq F, Munir S, et al. An insight into bisphenol A, food exposure and its adverse effects on health: A review. Front Nutr 2022; 9: 1047827.##Asadi-Fard Y, Zohour Soleimani M, Khodayar MJ, Khorsandi L, Shirani M, Samimi A. Morin improves bisphenol-A-induced toxicity in the rat testicular mitochondria and sperms. JBRA Assist Reprod 2023; 27: 174-179.##Khan S, Beigh S, Chaudhari BP, Sharma S, Aliul Hasan Abdi S, Ahmad S, et al. Mitochondrial dysfunction induced by bisphenol A is a factor of its hepatotoxicity in rats. Environ Toxicol 2016; 31: 1922-1934.##Wang Ch, Qi S, Liu Ch, Yang A, Fu W, Quan C, et al. Mitochondrial dysfunction and Ca2+ overload in injured Sertoli cells exposed to bisphenol A. Environ Toxicol 2017; 32: 823-831.##Tirichen H, Yaigoub H, Xu W, Wu C, Li R, Li Y. Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front Physiol 2021; 12: 627837.##Kaur S, Saluja M, Bansal MP. Bisphenol A induced oxidative stress and apoptosis in mice testes: Modulation by selenium. Andrologia 2018; 50: e12834.##Lemasters JJ. Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (type 3). Redox Biol 2014; 2: 749-754.##Koyano F, Yamano K, Kosako H, Tanaka K, Matsuda N. Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL. J Biol Chem 2019; 294: 10300-10314.##Choi M-S, Park H-J, Oh J-H, Lee E-H, Park S-M, Yoon S. Nonylphenol-induced apoptotic cell death in mouse TM4 Sertoli cells via the generation of reactive oxygen species and activation of the ERK signaling pathway. J Appl Toxicol 2014; 34: 628-636.##Gao Y, Mruk DD, Cheng CY. Sertoli cells are the target of environmental toxicants in the testis- a mechanistic and therapeutic insight. Expert Opin Ther Targets 2015; 19: 1073-1090.##Qi S, Fu W, Wang C, Liu C, Quan C, Kourouma A, et al. BPA-induced apoptosis of rat Sertoli cells through Fas/FasL and JNKs/p38 MAPK pathways. Reprod Toxicol 2014; 50: 108-116.##Feng Y, Wu J, Lei R, Zhang Y, Qiao M, Zhou J, et al. N-acetyl-L-cysteine ameliorates BPAF-induced porcine Sertoli cell apoptosis and cell cycle arrest via inhibiting the ROS level. Toxics 2023; 11: 923-937.##Amjad S, Rahman MS, Pang MG. Role of antioxidants in alleviating bisphenol A toxicity. Biomolecules 2020; 10: 1105-1131.##Han X, Parker TL. Antiinflammatory activity of cinnamon (Cinnamomum zeylanicum) bark essential oil in a human skin disease model. Phytother Res 2017; 31: 1034-1038.##Qiu M, Wei W, Zhang J, Wang H, Bai Y, Guo DA. A scientometric study to a critical review on promising anticancer and neuroprotective compounds: Citrus flavonoids. Antioxidants (Basel) 2023; 12: 669-692.##Pengnet S, Prommaouan S, Sumarithum P, Malakul W. Naringin reverses high-cholesterol diet-induced vascular dysfunction and oxidative stress in rats via regulating LOX-1 and NADPH oxidase subunit expression. Biomed Res Int 2019; 2019: 3708497.##Li F, Zhan Z, Qian J, Cao C, Yao W, Wang N. Naringin attenuates rat myocardial ischemia/reperfusion injury via PI3K/Akt pathway-mediated inhibition of apoptosis, oxidative stress and autophagy. Exp Ther Med 2021; 22: 811-819.##Hsueh TP, Sheen JM, Pang JH, Bi KW, Huang CC, Wu HT, et al. The anti-atherosclerotic effect of naringin is associated with reduced expressions of cell adhesion molecules and chemokines through NF-κB pathway. Molecules 2016; 21: 195-210.##Mohamed EE, Ahmed OM, Abdel-Moneim A, Zoheir KMA, Elesawy BH, Al Askary A, et al. Protective effects of naringin-dextrin nanoformula against chemically induced hepatocellular carcinoma in Wistar rats: Roles of oxidative stress, inflammation, cell apoptosis, and proliferation. Pharmaceuticals (Basel) 2022; 15: 1558-1582.##Alboghobeish S, Mahdavinia M, Zeidooni L, Samimi A, Oroojan AA, Alizadeh S, et al. Efficiency of naringin against reproductive toxicity and testicular damages induced by bisphenol A in rats. Iran J Basic Med Sci 2019; 22: 315-325.##Mehranfard N, Ghasemi M, Rajabian A, Ansari L. Protective potential of naringenin and its nanoformulations in redox mechanisms of injury and disease. Heliyon 2023; 9: e22820.##Elhemiely AA, Yahia R, Gad AM. Naringenin alleviate reproductive toxicity evoked by lead acetate via attenuation of sperm profile and biochemical alterations in male Wistar rat: Involvement of TGFβ/AKT/mTOR pathway. J Biochem Mol Toxicol 2023; 37: e23335.##Zhang Y, Han L, Yang H, Pang J, Li P, Zhang G, et al. Bisphenol A affects cell viability involved in autophagy and apoptosis in goat testis sertoli cell. Environ Toxicol Pharmacol 2017; 55: 137-147.##Mostafa H-S, Abd El-Baset SA, Kattaia AA, Zidan RA, Al Sadek MM. Efficacy of naringenin against permethrin-induced testicular toxicity in rats. Int J Exp Pathol 2016; 97: 37-49.##Sengul E, Gelen V, Yildirim S, Cinar İ, Aksu EH. Effects of naringin on oxidative stress, inflammation, some reproductive parameters, and apoptosis in acrylamide-induced testis toxicity in rat. Environ Toxicol 2023; 38: 798-808.##Gassman NR. Induction of oxidative stress by bisphenol A and its pleiotropic effects. Environ Mol Mutagen 2017; 58: 60-71.##Matic I, Strobbe D, Frison M, Campanella M. Controlled and impaired mitochondrial quality in neurons: Molecular physiology and prospective pharmacology. Pharmacol Res 2015; 99: 410-424.##Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 2013; 20: 31-42.##Anand SK, Sharma A, Singh N, Kakkar P. Activation of autophagic flux via LKB1/AMPK/mTOR axis against xenoestrogen Bisphenol-A exposure in primary rat hepatocytes. Food Chem Toxicol 2020; 141: 111314-111329.##Morshed AKMH, Paul S, Hossain A, Basak T, Hossain MS, Hasan MM, et al. Baicalein as promising anticancer agent: A comprehensive analysis on molecular mechanisms and therapeutic perspectives. Cancers (Basel) 2023; 15: 2128-2156.##Li S, Zhang J, Liu C, Wang Q, Yan J, Hui L, et al. The role of mitophagy in regulating cell death. Oxid Med Cell Longev 2021; 2021: 6617256.##Decker ST, Matias AA, Bannon ST, Madden JP, Alexandrou-Majaj N, Layec G. Effects of cigarette smoke on in situ mitochondrial substrate oxidation of slow- and fast-twitch skeletal muscles. Life Sci 2023; 315: 121376.##Song Y, Ding W, Xiao Y, Lu KJ. The progress of mitophagy and related pathogenic mechanisms of the neurodegenerative diseases and tumor. Neurosci J 2015; 2015: 543758.##Sun T, Ding W, Xu T, Ao X, Yu T, Li M, et al. Parkin regulates programmed necrosis and myocardial ischemia/reperfusion INGury by targeting cyclophilin-D. Antioxid Redox Signal 2019; 31: 1177-1193.##Paech F, Mingard C, Grünig D, Abegg VF, Bouitbir J, Krähenbühl S. Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells. Toxicology 2018; 395: 34-44.##Wang M, Luan S, Fan X, Wang J, Huang J, Gao X, et al. The emerging multifaceted role of PINK1 in cancer biology. Cancer Sci 2022; 113: 4037-4047.##Li W, Jiang WS, Su YR, Tu KW, Zou L, Liao CR, et al. PINK1/Parkin-mediated mitophagy inhibits osteoblast apoptosis induced by advanced oxidation protein products. Cell Death Dis 2023; 14: 88-100.##Wei Y, Sun L, Liu C, Li L. Naringin regulates endoplasmic reticulum stress and mitophagy through the ATF3/PINK1 signaling axis to alleviate pulmonary fibrosis. Naunyn Schmiedebergs Arch Pharmacol 2023; 396: 1155-1169.##Praharaj PP, Naik PP, Panigrahi DP, Bhol CS, Mahapatra KK, Patra S, et al. Intricate role of mitochondrial lipid in mitophagy and mitochondrial apoptosis: Its implication in cancer therapeutics. Cell Mol Life Sci 2019; 76: 1641-1652.##Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J, et al. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol 2019; 70: 66-77.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Features of the course of severe and critical COVID-19 in pregnant women: A prospective cross-sectional study</TitleF>
		<TitleE>ویژگی های سیر کووید-19 شدید و بحرانی در زنان باردار: یک مطالعه مقطعی آینده نگر</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: با شروع همه&#173;گیری بیماری کرونا ویروس 2019 (کووید-19)، مطالعات نشان داد که خطر ابتلا به نوع شدید این بیماری در زنان باردار بیشتر می&#173;باشد.
هدف: این مطالعه به بررسی ویژگی&#8204;های انواع شدید و بسیار شدید عفونت کووید-19 در زنان باردار می&#8204;پردازد.
مواد و روش&#173; ها: در این مطالعه مقطعی آینده&#8204;نگر، سوابق پزشکی 120 زن باردار مبتلا به کووید-19 شدید و بسیار شدید با هم مقایسه شد. این زنان در مرکز بیماری&#8204;های عفونی، شیمکنت، قزاقستان از دسامبر 2021 تا مه 2022 تحت درمان قرار گرفته بودند. عواملی مانند زمان بستری در بیمارستان، مدت دوره بستری، بیماری&#173;های همراه با حاملگی مادر، سن، عوارض بارداری و پس از زایمان، پیامدهای بارداری و نوع درمان مورد تجزیه و تحلیل قرار گرفت.
نتایج: 87 زن باردار (5/%72) مبتلا به کووید-19 شدید و 33 نفر (5/%27) با نوع بسیار شدید کووید-19 وارد مطالعه شدند. داده&#173;های زیر هنگام مقایسه تعداد حاملگی، بسته به سن حاملگی به دست آمد: در هفته&#173;های 12-1، این شاخص 95/0 &#177; 75/3 بود. در هفته&#173;های 27-13 شاخص 00/3 (00/00-4/2 :Q1-Q3)، در هفته&#173;های 40-28 شاخص 00/3 (00/4-00/2 :Q1-Q3). نتایج نشاندهنده این بود که عفونت شدید کووید-19 در زنان با بارداری سوم رخ می&#173;دهد&#160;&#160;&#160; &#160;(00/4-00/2 :Q1-Q3)Me 3.00 ).
نتیجه &#173;گیری: خطر پیشرفت بیماری به کووید-19 شدید و بسیار شدید در زنان باردار بالای 33 سال و در هفته&#8204;های 40-28 بارداری وجود دارد. ارجاع زودهنگام به پزشک در بیمارستان، بستری شدن به موقع و شروع درمان، خطر تشدید وضعیت بیمار و ایجاد عوارض وحشتناک را کاهش می&#173;دهد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: At the beginning of the Coronavirus disease 2019 (COVID-19) pandemic, studies showed that the risk of severe disease was higher in pregnant women.
Objective: This study investigates the characteristics of severe and critical types of COVID-19 coronavirus infection in pregnant women.
Materials and Methods: This prospective cross-sectional study compared the medical records of 120 pregnant women with severe and very severe COVID-19 treated at the Infectious Disease Center, Shymkent, Kazakhstan from December 2021 to May 2022. Factors such as time of hospital admission, hospitalization period, maternal comorbidities, age, pregnancy and postpartum complications, pregnancy outcomes, and treatment type were analyzed. 
Results: 87 (72.5%) pregnant women with severe and 33 (27.5%) with critical type of COVID-19 were included. The following data were obtained when comparing the pregnancy parity of the subjects, depending on the gestational age: in 1-12 wk, the indicator was 3.75 &#177; 0.95; in 13-27 wk 3.00 (Q1-Q3: 2.00-4.00), in 28-40 wk 3.00 (Q1-Q3: 2.00-4.00). Severe COVID-19 coronavirus infection occurs in women with more than a third pregnancy (Me 3.00 [Q1-Q3: 2.00-4.00]).
Conclusion: There is a risk of disease progression to severe and critical COVID-19 in pregnant women older than 33 yr of age and at 28-40 wk gestation. Early referral to a doctor in hospital, timely hospitalization, and initiated treatment reduces the risk of aggravation of the patient&#39;s condition and development of formidable complications.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>229</FPAGE>
			<TPAGE>234</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/192023/12/302023/11/112023/01/2
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/10/12
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/242024/02/282024/03/52024/03/7
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/17
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Gulbanu</Name>
				<MidName></MidName>
				<Family>Ganikyzy Shaimerdenova</Family>
				<NameE>Gulbanu</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ganikyzy Shaimerdenova</FamilyE>
				<Organizations>
				<Organization>South Kazakhstan Medical Academy, Shymkent, Kazakhstan.</Organization>
				</Organizations>
				<Countries>
				<Country>قزاقستان</Country>
				</Countries>
				<EMAILS>
				<Email>gulbanu1008@mail.ru</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Gulzhan</Name>
				<MidName></MidName>
				<Family>Narkenovna Abuova</Family>
				<NameE>Gulzhan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Narkenovna Abuova</FamilyE>
				<Organizations>
				<Organization>South Kazakhstan Medical Academy, Shymkent, Kazakhstan.</Organization>
				</Organizations>
				<Countries>
				<Country>قزاقستان</Country>
				</Countries>
				<EMAILS>
				<Email>dr.abuova@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Saltanat</Name>
				<MidName></MidName>
				<Family>Nalibekkyzy Kulbayeva</Family>
				<NameE>Saltanat</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nalibekkyzy Kulbayeva</FamilyE>
				<Organizations>
				<Organization>South Kazakhstan Medical Academy, Shymkent, Kazakhstan.</Organization>
				</Organizations>
				<Countries>
				<Country>قزاقستان</Country>
				</Countries>
				<EMAILS>
				<Email>saltanatkulbayeva@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>COVID-19</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnancy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Infection.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کووید-19</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بارداری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>عفونت.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Hui DS, Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-266.##World Health Organization. Novel coronavirus (2019-nCoV). Situation report 22. Available at: https://www.who.int/ docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. 11 February 2020.##Shchelkanov MY, Popova AY, Dedkov VG, Akimkin VG, Maleev VV. [The history of investigation and modern classification of coronaviruses (Nidovirales: Coronaviridae)]. Russian J Infect Immun 2020; 10: 221-246. (In Russian)##Estimated cumulative excess deaths per 100,000 people during COVID-19. Available at: https://ourworldindata.org/explorers/coronavirus-data-explorer 07/16/2022.##Data of the committee for sanitary and epidemiological control of the city of Shymkent, 2022. Available at: https://www.gov.kz/memleket/entities/departament-kkbtu-shymkent?lang=ru 07/16/2022.##Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. Int J Gynecol Obstet 2020; 150: 47-52.##Fan C, Lei D, Fang C, Li C, Wang M, Liu Y, et al. Perinatal transmission of 2019 coronavirus Disease: Associated severe acute respiratory syndrome coronavirus 2: Should we worry? Clin Infect Dis 2021; 72: 862-864.##Joseph NT, Collier AY. COVID-19 therapeutics and considerations for pregnancy. Obstet Gynecol Clin North Am 2023; 50: 163-182.##Shaimerdenova GG, Abuova GN, Saltanat S, Baimbetova S, Aidana A. Remdesevir antiviral therapy in pregnant women with COVID-19. Arch Clin Infect Dis 2023; 18: e132803.##Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Da Fonseca EB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr 2017; 171: 288-295.##Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9: 51-60.##Mehta P, Zimba O, Gasparyan AY, Seiil B, Yessirkepov M. Ethics committees: Structure, roles, and issues. J Korean Med Sci 2023; 38: e198.##Misra DP, Zimba O, Gasparyan AY. Statistical data presentation: A primer for rheumatology researchers. Rheumatol Int 2021; 41: 43-55.##Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: Clinical outcomes; mechanisms, and vaccine efficacy. Transl Res 2022; 251: 84-95.##Clinical protocol for the diagnosis and treatment of coronavirus infection COVID-19 in pregnant women, women in labor and puerperas of August 5, 2021. Available at: http://www.rcrz.kz/index.php/ru/2017-03-12-10-50-44/press-reliz/2365-press-reliz. 16.07.2022.##Kurmanova A, Urazbayeva G, Terlikbayeva A, Salimbaeva D, Ayazbekov A. Diagnostic significance of blood lymphocyte activation markers in pre-eclampsia. Clin Exp Immunol 2024; 215: 94-103.##Ayazbekov A, Nurkhasimova R, Kulbayeva S, Bolat K, Kurmanova AM, Yeskarayeva A, et al. Features of pregnancy, childbirth and postpartum period of young mothers. Electron J Gen Med 2020; 17: em260.##Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstet Gynecol 2020; 222: 415-426.##Bayakhmetova M, Abuova GN, Bukharbayev YB, Ablyazimov TN, Kamytbekova KZ, Baimbetova S. Q fever in individuals in the Eurasian continent: A 50-year literature review (1973-2022). Arch Clin Infect Dis 2023; 18: e136333.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Human Vα7.2-Jα33 mucosal-associated invariant T cells in endometrial ectopic tissues tend to produce interferon-gamma: A new player in endometriosis etiology: A case-control study</TitleF>
		<TitleE>سلول های T ثابت مرتبط با مخاط V𝜶7.2-J𝜶33 انسان در بافت های نابجای آندومتر تمایل به تولید اینترفرون گاما دارند: بازیگری جدید در علت آندومتریوز: یک مطالعه مورد-شاهدی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: آندومتریوز یک اختلال التهابی مزمن مرتبط با استروژن است که با تکثیر سلول&#173;های آندومتر در مکانی خارج از رحم شناخته می&#173;شود. حضور زیاد&#160;&#160;&#160;&#160; &#160;سلول&#173;های ایمنی در مایع صفاقی زنان مبتلا به اندومتریوز، دخالت سیستم ایمنی در پاتوژنز بیماری را تأیید می&#173;کند. سلول&#173;های MAIT با تولید IL-17، IFN-&#947; و TNF-&#945;، تأثیر غیرقابل انکاری بر ایمنی مخاط ایفا می&#173;کنند. عملکرد این سلول&#173;ها در پاتوژنز اندومتریوز کمتر مورد بررسی قرار گرفته است.
هدف: هدف از این مطالعه بررسی نفوذ سلول MAIT با استفاده از تعیین سطح بیان ژن&#8204;های Va7.2-J&#945;33 در بافت یوتوپیک و اکتوپیک ضایعات آندومتریوز است.
مواد و روش&#173; ها: در مطالعه مورد-شاهدی، نمونه&#173;های مورد آزمایش شامل 20 بافت اوتوپیک و 20 بافت نابجا زنان مبتلا به اندومتریوز و 20 بافت آندومتر رحم زنان در گروه شاهد بود. بیان ژن&#173;های TNF-&#945;، IL-17A، IFN-&#947; توسط (q-RT-PCR) مورد تجزیه و تحلیل قرار گرفت.
نتایج: بر اساس نتایج مطالعه، بیان ژن&#8204;های Va7.2-J&#945;33 در رحم و بافت&#8204;های یوتوپیک آندومتر در مقایسه با کنترل داخلی ژن و همچنین در بافت&#8204;های نابجا، افزایش قابل &#8204;توجهی را نشان نداد. تجزیه و تحلیل همبستگی یک رابطه مثبت بین ژن&#173;های بیان V&#945;7.2-J&#945;33 و سطوح IFN-&#947; در بافت&#173;های نابجا تأیید کرد.
نتیجه&#173; گیری: با توجه به بیان کم ژن اختصاصی سلول&#8204;های MAIT در بافت نابجا، می&#8204;توان نتیجه گرفت که این سلول&#8204;ها به میزان کمی در محیط اندومتریوز حضور دارند و با ترشح IFN-&#947; احتمال نقش آنها در پیشرفت اندومتریوز وجود دارد.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Endometriosis is a chronic estrogen-related inflammatory disorder that is known by proliferating endometrial cells in a place outside the uterus. The high presence of immune cells in the peritoneal fluid of women with endometriosis confirms the involvement of the immune system in the pathogenesis of the disease. Mucosal-associated invariant T (MAIT) cells play an undeniable impact on mucosal immunity by the production of interleukin-17, interferon-gamma (IFN-&#947;), and tumor necrosis factor-alpha. The function of the cells in the pathogenesis of endometriosis is less investigated. 
Objective: This study aims to investigate the infiltration of MAIT cells by using the determination levels of V&#945;7.2-J&#945;33 gene expression in eutopic and ectopic tissue of endometriosis lesions.
Materials and Methods: In this case-control study, the tested samples include 20 eutopic and 20 ectopic tissues of women with endometriosis and 20 uterine endometrial tissues of women in the control group. Expressions of the V&#945;7.2-J&#945;33 tumor necrosis factor-alpha, interleukin-17A, and IFN-&#947; genes were analyzed by quantitative reverse transcriptase-polymerase chain reaction. 
Results: According to the results, V&#945;7.2-J&#945;33 gene expression did not show substantial elevation in the uterine and eutopic endometrial tissues compared to internal gene control as well as in ectopic tissues. Correlation analysis approved a positive relationship between V&#945;7.2-J&#945;33 expression genes and IFN-&#947; levels in ectopic tissues.
Conclusion: Considering the low-expression specific gene of MAIT cells in ectopic tissue, it can be concluded that these cells are present in the endometriotic environment to a certain extent, and there is a possibility of their role in the progression of endometriosis by secreting IFN-&#947;.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>235</FPAGE>
			<TPAGE>244</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/192023/12/302023/11/112023/01/22023/08/27
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/6/5
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/242024/02/282024/03/52024/03/72024/03/9
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/19
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Zare Moghaddam</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zare Moghaddam</FamilyE>
				<Organizations>
				<Organization>Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>zmary1371@GMAIL.COM</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fateme</Name>
				<MidName></MidName>
				<Family>Zare</Family>
				<NameE>Fateme</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zare</FamilyE>
				<Organizations>
				<Organization>Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Fatemezare91@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Reyhane</Name>
				<MidName></MidName>
				<Family>Sandoghsaz</Family>
				<NameE>Reyhane</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sandoghsaz</FamilyE>
				<Organizations>
				<Organization>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Reyhane.sandoghsaz@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Abbas</Name>
				<MidName></MidName>
				<Family>Khalil</Family>
				<NameE>Abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khalil</FamilyE>
				<Organizations>
				<Organization>Department of Pediatrics, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Email:abbas_khalili_30@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Shams</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shams</FamilyE>
				<Organizations>
				<Organization>Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>alis743@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Endometriosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MAIT</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IFN-γ</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TNF-α</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TCR V alpha 7.2-J alpha33</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IL-17.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آندومتریوزیس</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MAIT</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IFN-γ</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TNF-α</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TCR V alpha 7.2 J alpha33</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IL-17.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: The genetic/epigenetic theory. Fertil Steril 2019; 111: 327-340.##Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 2017; 6: 34-41.##Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol 2017; 209: 3-7.##Zare Moghaddam M, Ansariniya H, Seifati SM, Zare F, Fesahat F. Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators. Am J Reprod Immunol 2022; 87: e13537.##Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, et al. Nonmotor fluctuations: Phenotypes, pathophysiology, management, and open issues. J Neural Transm 2017; 124: 1029-1036.##Xiao F, Liu X, Guo SW. Platelets and regulatory T cells may induce a type 2 immunity that is conducive to the progression and fibrogenesis of endometriosis. Front Immunol 2020; 11: 610963.##Zhang T, Zhou J, Man GCW, Leung KT, Liang B, Xiao B, et al. MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. Eur J Immunol 2018; 48: 1059-1073.##Legoux F, Salou M, Lantz O. MAIT cell development and functions: The microbial connection. Immunity 2020; 53: 710-723.##Nel I, Bertrand L, Toubal A, Lehuen A. MAIT cells, guardians of skin and mucosa? Mucosal Immunol 2021; 14: 803-814.##Meierovics A, Yankelevich W-JC, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci 2013; 110: E3119-E3128.##Bister J, Crona Guterstam Y, Strunz B, Dumitrescu B, Haij Bhattarai K, Özenci V, et al. Human endometrial MAIT cells are transiently tissue resident and respond to Neisseria gonorrhoeae. Mucosal Immunol 2021; 14: 357-365.##Gibbs A, Leeansyah E, Introini A, Paquin-Proulx D, Hasselrot K, Andersson E, et al. MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation. Mucosal Immunol 2017; 10: 35-45.##Xu H, Zhao J, Lu J, Sun X. Ovarian endometrioma infiltrating neutrophils orchestrate immunosuppressive microenvironment. J Ovarian Res 2020; 13: 44.##Li C, Lu Z, Bi K, Wang K, Xu Y, Guo P, et al. CD4+/CD8+ mucosa-associated invariant T cells foster the development of endometriosis: A pilot study. Reprod Biol Endocrinol 2019; 17: 78.##Chiang CM, Hill JA. Localization of T cells, interferon-gamma and HLA-DR in eutopic and ectopic human endometrium. Gynecol Obstet Invest 1997; 43: 245-250.##Qiu X-M, Lai Z-Z, Ha S-Y, Yang H-L, Liu L-B, Wang Y, et al. IL-2 and IL-27 synergistically promote growth and invasion of endometriotic stromal cells by maintaining the balance of IFN-γ and IL-10 in endometriosis. Reproduction 2020; 159: 251-260.##Zhang Q, Li P, Zhou W, Fang S, Wang J. Participation of increased circulating MAIT cells in lung cancer: A pilot study. J Cancer 2022; 13: 1623-1629.##Fan Q, Nan H, Li Z, Li B, Zhang F, Bi L. New insights into MAIT cells in autoimmune diseases. Biomed Pharmacother 2023; 159: 114250.##Podgaec S, Dias Junior JA, Chapron C, Oliveira RM, Baracat EC, Abrão MS. Th1 and Th2 ummune responses related to pelvic endometriosis. Rev Assoc Med Bras 2010; 56: 92-98.##Yoo J-Y, Jeong J-W, Fazleabas AT, Tayade C, Young SL, Lessey BA. Protein inhibitor of activated STAT3 (PIAS3) is down-regulated in eutopic endometrium of women with endometriosis. Biol Reprod 2016; 95: 11.##Ahn SH, Edwards AK, Singh SS, Young SL, Lessey BA, Tayade C. IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors. J Immunol 2015; 195: 2591-2600.##Miller JE, Ahn SH, Marks RM, Monsanto SP, Fazleabas AT, Koti M, et al. IL-17A modulates peritoneal macrophage recruitment and M2 polarization in endometriosis. Front Immunol 2020; 11: 108.##Hana T, Terabe M. MAIT cells and MR1 play an immunosuppressive role in glioblastoma through the induction of neutrophils and MDSCs. bioRxiv. 2022:2022.07.17.499189. (Preprint)##He R, Liu X, Zhang J, Wang Z, Wang W, Fu L, et al. NLRC5 inhibits inflammation of secretory phase ectopic endometrial stromal cells by up-regulating autophagy in ovarian endometriosis. Front Pharmacol 2020; 11: 1281.##Odukoya OA, Ajjan R, Lim K, Watson P, Weetman AP, Cooke I. The pattern of cytokine mRNA expression in ovarian endometriosis. Mol Hum Reprod 1997; 3: 393-397.##Koval HD, Chopyak VV, Kamyshnyi OM, Kurpisz MK. Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Cent Eur J Immunol 2018; 43: 90-96.##Shi XY, Gu L, Chen J, Guo XR, Shi YL. Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J Mol Med 2014; 33: 59-67.##Wu Y, Wu X. [Expression of PROK 1 and its receptor PROKR 1 in endometriosis and its clinical significance]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2019; 44: 621-627. (in Chinese)##Chae U, Min JY, Kim SH, Ihm HJ, Oh YS, Park SY, et al. Decreased progesterone receptor B/A ratio in endometrial cells by tumor necrosis factor-alpha and peritoneal fluid from patients with endometriosis. Yonsei Med J 2016; 57: 1468-1474.##Kim YA, Kim JY, Kim MR, Hwang KJ, Chang DY, Jeon MK. Tumor necrosis factor-alpha-induced cyclooxygenase-2 overexpression in eutopic endometrium of women with endometriosis by stromal cell culture through nuclear factor-kappaB activation. J Reprod Med 2009; 54: 625-630.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Corrigendum to “The effect of topical endometrial scratching on pregnancy outcome in women with previous failure of intrauterine insemination: A non-randomized clinical trial” [Int J Reprod BioMed 2021; 19: 465-470]</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>The publisher has been informed of an error that occurred on page 465 in which the first author affiliation order is incorrect and should be replaced with each other. On behalf of the author, the publisher wishes to apologize for this error. The online version of article has been updated on 30 March 2024.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>245</FPAGE>
			<TPAGE>245</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/08/162023/10/292023/07/192023/12/302023/11/112023/01/22023/08/272024/04/30
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1403/2/11
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2024/03/32024/03/112024/02/242024/02/282024/03/52024/03/72024/03/92024/03/11
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/12/21
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Farahnaz</Name>
				<MidName></MidName>
				<Family>Farzaneh</Family>
				<NameE>Farahnaz</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farzaneh</FamilyE>
				<Organizations>
				<Organization>Endometriosis Research Center, Iran University of medical Sciences, Tehran, Iran.  Infectious Disease and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Farahnaz1826@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farzaneh</Name>
				<MidName></MidName>
				<Family>Khastehfekr</Family>
				<NameE>Farzaneh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khastehfekr</FamilyE>
				<Organizations>
				<Organization>Zahedan University of Medical Science, Zahedan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>pregnancy</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
